Advertising
The TGA regulates advertisements for therapeutic goods. You need to know if that includes the product you intend to advertise.
Advertising non-compliance reports and investigation outcomes
Latest alerts
-
Robust Extreme capsules pose a serious risk to your health and should not be taken.
-
The TGA is warning consumers against taking EVE branded products that contain allylisopropylacetylurea (apronal) as they pose a significant health risk and are prohibited from sale, supply or use in Australia.
-
The TGA has detected fake semaglutide, also known as Ozempic, being illegally imported into Australia.
Latest articles
-
TGA warns advertising prescription-only weight-loss medicine is prohibited
The TGA reminds businesses and media outlets that it is unlawful to publicly advertise prescription-only medicines, including prescription-only weight loss medicines. -
Telehealth businesses fined over $300,000 for alleged unlawful advertising of weight loss medicines
Infringement notices were issued to businesses and individuals for the alleged unlawful advertising of prescription-only medicines on their websites. -
News Life Media fined for alleged unlawful advertising of medicinal cannabis
TGA has issued 3 infringement notices totalling $56,340 to News Life Media Pty Ltd for alleged unlawful advertising of medicinal cannabis on their popular lifestyle website Body+Soul.
Latest publications
-
This plan outlines the compliance and education priorities of the Therapeutic Goods Administration for 2024.
-
Communique from the meeting of the TGACC
-
The strategy outlines the approach we will use to identify, engage with, and educate stakeholders about regulatory requirements and our compliance outcomes.
This webpage on the TGA website was printed on 14 Sep 2024. Printed content may be out of date. For up-to-date information, always refer to the digital version: https://www.tga.gov.au/how-we-regulate/advertising